Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Ormat Technologies | ORA | 22. nov 2024 | 80.74 | +0.82 |
Orrstown Financial Services | ORRF | 22. nov 2024 | 40.49 | +1.35 |
Orthofix Medical | OFIX | 22. nov 2024 | 18.91 | +1.23 |
OrthoPediatrics | KIDS | 22. nov 2024 | 26.34 | -0.49 |
Oruka Therapeutics | ORKA | 22. nov 2024 | 20.75 | 0.00 |
OS Therapies | OSTX | 22. nov 2024 | 1.95 | +5.11 |
Oscar Health A | OSCR | 22. nov 2024 | 15.98 | -2.02 |
Oshkosh | OSK | 22. nov 2024 | 111.81 | +2.27 |
OSI Systems | OSIS | 22. nov 2024 | 164.91 | -0.25 |
Osisko Development | ODV | 22. nov 2024 | 1.84 | -3.16 |
Osisko Gold Royalties | OR | 22. nov 2024 | 20.11 | +1.26 |
Ostin Technology Group | OST | 22. nov 2024 | 0.22 | +0.46 |
Otis Worldwide | OTIS | 22. nov 2024 | 101.20 | +1.25 |
Otter Tail | OTTR | 22. nov 2024 | 80.78 | +0.25 |
Ouster | OUST | 22. nov 2024 | 9.53 | +6.24 |
Outbrain | OB | 22. nov 2024 | 5.05 | -0.98 |
Outfront Media | OUT | 22. nov 2024 | 19.13 | +1.00 |
Outlook Therapeutics | OTLK | 22. nov 2024 | 5.03 | -1.95 |
Outset Medical | OM | 22. nov 2024 | 0.84 | +10.15 |
Ovid Therapeutics | OVID | 22. nov 2024 | 1.05 | -0.94 |
Ovintiv | OVV | 22. nov 2024 | 46.71 | +0.26 |
Owens & Minor | OMI | 22. nov 2024 | 12.35 | +0.98 |
Owens Corning | OC | 22. nov 2024 | 202.77 | +2.63 |
Owlet A | OWLT | 22. nov 2024 | 4.62 | +1.54 |
Oxbridge Re | OXBR | 22. nov 2024 | 3.05 | -1.29 |
Oxford Industries | OXM | 22. nov 2024 | 77.80 | +2.03 |
Oxford Lane Capital | OXLC | 22. nov 2024 | 5.22 | +0.19 |
Oxford Lane Capital 2027 Pref | OXLCP | 22. nov 2024 | 24.08 | +0.00 |
Oxford Square Capital | OXSQ | 22. nov 2024 | 2.62 | -0.76 |
P.A.M. Transportation Services | PTSI | 22. nov 2024 | 19.72 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.